Cruz-Bermúdez, A., Vicente-Blanco, R. J., Laza-Briviesca, R., García-Grande, A., Laine-Menéndez, S., Gutiérrez, L., . . . Provencio, M. (2017). PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy. Sci Rep.
शिकागो स्टाइल उद्धरणCruz-Bermúdez, Alberto, et al. "PGC-1alpha Levels Correlate With Survival in Patients With Stage III NSCLC and May Define a New Biomarker to Metabolism-targeted Therapy." Sci Rep 2017.
एमएलए उद्धरणCruz-Bermúdez, Alberto, et al. "PGC-1alpha Levels Correlate With Survival in Patients With Stage III NSCLC and May Define a New Biomarker to Metabolism-targeted Therapy." Sci Rep 2017.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.